Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors

Objective: The optimal timing of measurable residual disease (MRD) evaluation in acute myeloid leukemia (AML) patients has not been well defined yet. We aimed to investigate the impact of MRD in pre- and post-allogeneic hematopoietic stem cell transplantation (AHSCT) periods on prognostic parameters...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Zehra Narlı Özdemir, Uğur Şahin, Klara Dalva, Mehmet Akif Baltacı, Atilla Uslu, Cemaleddin Öztürk, Güldane Cengiz Seval, Selami Koçak Toprak, Meltem Kurt Yüksel, Pervin Topçuoğlu, Önder Arslan, Muhit Özcan, Meral Beksaç, Osman İlhan, Günhan Gürman, Sinem Civriz Bozdağ
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Turkish Society of Hematology 2021-06-01
Saila:	Turkish Journal of Hematology
Gaiak:	acute myeloid leukemia measurable residual disease multiparameter flow cytometry
Sarrera elektronikoa:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-86846
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!